medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2009, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2009; 7 (3)

Treatment of pityriasis lichenoides and varioliformis acuta with pulsed light dye laser VBeam. Case Report

Gutiérrez GC, Anides FA, Vallarta RA, Andrade DL, Fernández AG, Padilla BT, Landgrave GI, López TB, Carbajal PP, Bernal RE, Ávila RA

Language: Spanish
References: 16
Page: 191-193
PDF size: 81.21 Kb.


ABSTRACT

Pityriasis lichenoides (PL) is a papulosquamous disorder of unknown etiology with acute and chronic clinical forms. Pityriasis lichenoides chronica (PLC) is a mild and persistent form, and pityriasis lichenoides ET Varioliformis Actua (PLEVA) is the end of the disease spectrum. Traditional treatment is a combination of topical drugs and phototherapy. We report a 17 year-old female, with papulosquamous lesions on the chest and upper limbs. She was treated previously for 8 years with emollients, systemic and topical corticosteroids; and in the last year with methotrexate with partial response. The patient had a good clinical response after 25 sessions with pulsed light dye laser (VBeam). We report therapeutic alternative in patients with poor response to traditional management.


REFERENCES

  1. 1 Magro C, Crowson AN, Kovatich A et al. “Pityriasis lichenoides: A clonal T-cell lymphoproliferative disorder”. Hum Pathol 2002; 33: 788-795.

  2. 2 Tomasini D, Zampatti C, Palmedo G et al. “Cytotoxic mycosis fungoides evolving from pityriasis lichenoides chronica in a seventeen-yearold- girl: Report of a case”. Dermatology 2002; 205: 176-179.

  3. 3 McKee PH. “Pytiriasis lichenoides, in vascular diseases”. En McKee PH (ed.), Pathology of the skin with clinical correlations. 2a. ed. Londres. Mosby-Wolfe 1996; 5.8-5.11.

  4. 4 Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. México, Mc- Graw-Hill Interamericana. México. 2006; 476-478.

  5. 5 Pavlotsky F, Baum S, Barzilai A, Shapiro D, Trau H. “UVB therapy of pityriasis lichenoides—Our experience with 29 patients”. JEADV 2006; 20: 542-547.

  6. 6 Nair PS. “A clinical and histopathological study of pityriasis lichenoides”. Indian J Dermatol Venereol Leprol 2007; 73(2): 100-102.

  7. 7 Piamphongsant T. “Tetracycline for the treatment of pityriasis lichenoides”. Br J Dermatol 1974; 91: 319-322.

  8. 8 Simon D, Boudny C, Nievergelt H, Simon H-U, Braathen LR. “Successful treatment of pityriasis lichenoides with topical tacrolimus”. Br J Dermatol 2004, 150: 1028-1054.

  9. 9 Tomasini D, Tomasini CF, Cerri A, Sangalli G, Palmedo G, Hantschke M, Kutzner H. “Pityryasis lichenoides: A cytotoxic T-cellmediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases”. J Cutan Pathol 2004; 31: 531-538.

  10. 10 Khachemoune A, Blyumin ML. “Pityriassis lichenoides pathophysiology. Classification and treatment”. Am J Clin Dermatol 2007; (8): 29-36.

  11. Rabinowitz LG. “Lichen sclerosus et atrophicus treatment with the 585-nm flash lamp-pumped pulsed dye laser”. Arch Dermatol 1993; 129: 381-382.

  12. Hacker SM, Rasmussen JE. “The effect of flash lamp-pulsed dye laser on psoriasis”. Arch Dermatol 1992; 128: 853-855.

  13. Alster TS. “Improvement of erythematous and hypertrophic scars by the 585 nm flash lamp-pumped pulsed dye laser”. Ann Plast Surg 1994; 32: 186-190.

  14. Ross BS, Levine VJ, Nehal K et al. “Pulsed dye laser treatment of warts: An update”. Dermatol Surgery 1999; 25: 377-380.

  15. Gutiérrez GC, Gutiérrez A, Ávila A y cols. “Tratamiento láser de lesiones vasculares”. Cir Plast 2007; 17(2): 121-132.

  16. Pasic A, Ceovic R, Lipozencie J et al. “Phototherapy in pediatric patients”. Pediatr Dermatol 2003; 20(1): 71-77.




2020     |     www.medigraphic.com